Global Cooperation
"The meaning of pharmaceutical innovation is to bring eternal hope to human life and health"
Danatlas is committed to developing "world's first (FIC)" target drugs in the era of precision targeted therapy for oncology 2.0 to meet the clinical needs of patients and promote medical innovation.
With an international perspective, we comprehensively select and develop strategic partnerships on a global scale. In all stages of drug discovery, clinical research and commercialization, we cooperate extensively with scientific research institutions, pharmaceutical companies, investment and industrial institutions around the world through external licensing, cooperative research and development, joint development, etc., in order to bring more effective products to the global market as soon as possible and benefit patients.